ストックスクリーナーアプリを入手
12.81
4.06%
0.50
前日終値:
$12.31
開ける：
$12.5
24時間の取引高:
3.95M
Relative Volume:
1.05
時価総額：
$1.42B
収益：
$631.73M
当期純損益:
$-239.78M
株価収益率:
-6.3416
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-3.76%
1か月 パフォーマンス:
+0.08%
6か月 パフォーマンス:
+6.75%
1年 パフォーマンス:
-34.81%
1日の値動き範囲:
$12.27
$13.09
1週間の範囲:
$11.88
$14.49
52週間の値動き範囲:
$6.78
$24.76
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
12.81 | 1.53B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
275.43 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
66.34 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.82 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.98 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.58 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
Price Floor Holding on 10x Genomics Inc. — Rebound PossibleBuy Alerts With Low Risk Confirmation Noted - 선데이타임즈
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know - Yahoo Finance
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know | FinancialContent - FinancialContent
Does 10x Genomics Inc. offer margin of safetyFree Weekly Earnings Watchlist - thegnnews.com
Zacks.com featured highlights include Tsakos Energy Navigation Limited, 10x Genomics, Pan American Silver, Wolverine World Wide and Interface - TradingView
Will Breakout in 10x Genomics Inc. Sustain Through Next WeekIntraday Trend Analysis for Fast Gains Released - beatles.ru
10x Genomics to Acquire Scale Biosciences - FinSMEs
10x Genomics Sees Strong Growth with Q2 Results, Strategic Acquisition, and Optimistic Outlook - AInvest
Why 10x Genomics (TXG) Is Down 6.0% After Tariff-Driven Q2 Revenue Surge and Guidance Update - simplywall.st
10x Genomics shares rise 1.71% after-hours following Q2 revenue beat and Deutsche Bank price target adjustment. - AInvest
10x Genomics: UBS maintains a 'Neutral' Rating, The Target Price is $13 - AInvest
10x Genomics (NASDAQ:TXG Shareholders Incur Further Losses as Stock Declines 4.8% This Week, Taking Five-year Losses to 88% - 富途牛牛
Why 10x Genomics (TXG) Stock Is Falling Today - FinancialContent
10x Genomics, Inc. SEC 10-Q Report - TradingView
10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars - Yahoo Finance
10x Genomics Inc (TXG) Q2 2025 Earnings Call Highlights: Navigating Revenue Shifts and ... By GuruFocus - Investing.com Canada
10x Genomics Inc (TXG) Q2 2025 Earnings Call Highlights: Navigat - GuruFocus
10x Genomics Invests in the Future with Scale Biosciences Acquisition, Eyes Scalable Growth - geneonline.com
10X Genomics Outpaces Estimates And Returns To Profit - Finimize
10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
10X Genomics' Q2 revenue beats estimates - MarketScreener
10x Genomics: Q2 Earnings Snapshot - San Antonio Express-News
10x Genomics to acquire Scale Biosciences to expand single cell analysis - Investing.com
Earnings Flash (TXG) 10x Genomics, Inc. Reports Q2 Revenue $172.9M, vs. FactSet Est of $139.4M - MarketScreener
(TXG) 10x Genomics, Inc. Expects Q3 Revenue Range $140.0M$144.0M - MarketScreener
10x Genomics Reports Second Quarter 2025 Financial Results – Company Announcement - Financial Times
10x Genomics To Acquire Scale Biosciences - Barchart.com
Transcript : 10x Genomics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Earnings To Watch: 10x Genomics (TXG) Reports Q2 Results Tomorrow - Yahoo Finance
10x Genomics Inc. Recovery Potential Based on Technical ToolsScalable Portfolio Growth Suggestions Released - metal.it
Is 10x Genomics Inc. a growth stock or a value stockHigh-octane investment opportunities await - Jammu Links News
What is the dividend policy of 10x Genomics Inc. stockOverwhelming profit margins - Jammu Links News
What are analysts’ price targets for 10x Genomics Inc. in the next 12 monthsFree Predictions - Jammu Links News
Is 10x Genomics Inc. stock overvalued or undervaluedDynamic profit opportunities - Jammu Links News
What catalysts could drive 10x Genomics Inc. stock higher in 2025Remarkably fast returns - Jammu Links News
What are 10x Genomics Inc. company’s key revenue driversAchieve breakthrough performance with smart picks - Jammu Links News
What is the risk reward ratio of investing in 10x Genomics Inc. stockBuild wealth with steady, reliable stocks - Jammu Links News
What institutional investors are buying 10x Genomics Inc. stockRobust investment performance - Jammu Links News
10x Genomics' (TXG) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
When is 10x Genomics Inc. stock expected to show significant growthDaily Trading Signals That Work - Jammu Links News
Options Data Show Bullish Bias in 10x Genomics Inc.Smart Money Tracking Signal Generator Activated - metal.it
Building trade automation scripts for 10x Genomics Inc.Low Risk Picks for Daily Trading Released - metal.it
10x Genomics Inc. Recovery Likely Here’s What Data ShowsFree Signals Group - beatles.ru
10x Genomics Inc. Price Targets Raised After ReboundWeekly Setup With 3x Return Potential Published - metal.it
10x Genomics Inc. Stock Lags Behind Sector BenchmarksInvestment Plan With Growth Optimization Finalized - beatles.ru
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know - TradingView
Why 10x Genomics Inc. stock attracts strong analyst attentionReliable Investment Entry Signals Confirmed by Charts - beatles.ru
RSI and MACD Indicate Shift in 10x Genomics Inc. SentimentEntry Alert Based on Volume Spikes Detected - metal.it
AI Trend Models Suggest Bounce for 10x Genomics Inc.Market Entry and Exit Point Tips From Traders - metal.it
Is 10x Genomics Inc. Starting a New UptrendWealth Building Stock Market Ideas Based on Momentum - beatles.ru
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
0.30%
1.97%
大文字化:
|
ボリューム (24 時間):